The Russian Sputnik V vaccine against it will be produced in Egypt coronavirus.
Egyptian pharmaceutical company Minapharm agrees to produce more than 40 million doses a year of Sputnik V, as announced today by the Russian Direct Investment Fund (RDIF), which promotes the vaccine abroad.
The two sides agreed to start technology transfer immediately, RDIF said in a joint statement with Minapharm, and The vaccine is expected to be available in the third quarter of this year.
“RDIF and Minapharm will initially provide over 40 million doses a year. The production will take place at the Minapharm biotechnology facility in Cairo for global distribution “, according to the announcement of the two companies, which is cited by AMPE.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
